"It’s time to implement changes that comply with EU legislation," stated MP Kuzminykh.

Recently, an important meeting took place at the subcommittee on pharmacy and pharmaceutical activities, involving representatives from the pharmaceutical business, distributors, pharmacy chains, and relevant associations. The initiative was led by the subcommittee chairman, people's deputy Sergey Kuzminykh, who invited all interested market participants for an open discussion on the future draft law regulating pharmaceutical activities, as reported by UNN.

The key message from this meeting was the importance of open dialogue and a comprehensive approach. Sergey Kuzminykh emphasized that the new legislative initiative would be developed from scratch, taking into account the opinions of all market participants, rather than through piecemeal amendments to draft law No. 11493. He firmly opposed fragmented amendments and highlighted the need for a systematic, European-style draft law that would ensure fair and transparent regulation of pharmaceutical activities.

One of the important points made by the people's deputy was the necessity of viewing the pharmaceutical market as a whole. This involves not just individual aspects, such as limiting distributors or introducing an electronic procurement catalog. The law must clearly define the fundamental rules of pharmaceutical activity, guarantees for market participants, and mechanisms for pricing and control.

"Everyone understands that it is time to make certain changes, and they must align with European legislation. We advocate for systematic regulation of the market according to the best standards and practices, so that manufacturers, distributors, and pharmacies all understand their rights and opportunities, while ensuring that the pharmaceutical market operates in a civilized manner," Kuzminykh stressed.

The deputy once again confirmed the necessity of listening to all participants in the process—from manufacturers to pharmacies—to ensure that the future law does not create imbalances or hinder the development of the pharmaceutical market. Thus, the clear position of the initiator of a comprehensive separate draft law regulating the pharmaceutical market raises hopes that only a European approach and transparent rules will ensure stability, accessibility of medicines, and effective functioning of the industry.

Recall

On January 24, during a meeting of the committee on national health, Ukraine's Minister of Health Viktor Lyashko presented the concept of reforming the regulation of the pharmaceutical market. The proposals from the Ministry of Health included reducing drug prices through electronic trading among manufacturers, limiting discount sizes, and banning retro bonuses. Not all proposed changes were well-received by the people's deputies, leading to the decision to develop a separate draft law that would cover all aspects of the pharmaceutical market's functioning. It must consider the rights and responsibilities of manufacturers, distributors, and pharmacy chains.